Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient
Objective: Umbilical cord blood (UCB) represents a valuable graft source in the absence of a human leukocyte antigen (HLA)-matched donor for hematopoietic cell transplantation (HCT). Donor-specific anti-HLA antibodies (DSAs), targeting grafts with mismatched HLA antigens, pose a significant obstacle...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2448552 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556858680115200 |
|---|---|
| author | Mégane Tanguay Sandra Cohen Isabelle Ménard Marie-Christine Meunier Jean-Sébastien Delisle Jean Roy Olivier Veilleux Imran Ahmad |
| author_facet | Mégane Tanguay Sandra Cohen Isabelle Ménard Marie-Christine Meunier Jean-Sébastien Delisle Jean Roy Olivier Veilleux Imran Ahmad |
| author_sort | Mégane Tanguay |
| collection | DOAJ |
| description | Objective: Umbilical cord blood (UCB) represents a valuable graft source in the absence of a human leukocyte antigen (HLA)-matched donor for hematopoietic cell transplantation (HCT). Donor-specific anti-HLA antibodies (DSAs), targeting grafts with mismatched HLA antigens, pose a significant obstacle by increasing the risk of primary graft failure, delayed engraftment, and decreased survival. Existing literature on HLA desensitization has primarily focused on haploidentical transplants, and there is a lack of experience regarding the optimal strategy in UCB transplantation.Methods: We report our successful desensitization strategy in a 42-year-old woman with acute lymphoblastic leukemia receiving a single UCB unit. The only suitable donor option for this patient, who had no relatives and uncommon HLA haplotypes, was a UCB graft against which the patient had DQ7 DSAs.Results: DSA levels were reduced before transplantation through a combination of plasma exchange, intravenous immunoglobulins, and rituximab with close monitoring of DSA mean fluorescent intensity levels. After desensitization, the patient underwent UCB transplantation, achieved successful engraftment and remained in complete remission, free from graft-versus-host disease.Conclusion: When other suitable donors without DSAs are unavailable, our desensitization modality offers a safe option for single-unit UCB transplantation. |
| format | Article |
| id | doaj-art-5398b91f22f84a169b89904d753ff3ae |
| institution | Kabale University |
| issn | 1607-8454 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Hematology |
| spelling | doaj-art-5398b91f22f84a169b89904d753ff3ae2025-01-07T05:58:57ZengTaylor & Francis GroupHematology1607-84542025-12-0130110.1080/16078454.2024.2448552Successful desensitization of donor-specific antibodies in a single cord blood transplant recipientMégane Tanguay0Sandra Cohen1Isabelle Ménard2Marie-Christine Meunier3Jean-Sébastien Delisle4Jean Roy5Olivier Veilleux6Imran Ahmad7Cellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaCellular Therapy & Transplantation Program, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, Quebec, CanadaObjective: Umbilical cord blood (UCB) represents a valuable graft source in the absence of a human leukocyte antigen (HLA)-matched donor for hematopoietic cell transplantation (HCT). Donor-specific anti-HLA antibodies (DSAs), targeting grafts with mismatched HLA antigens, pose a significant obstacle by increasing the risk of primary graft failure, delayed engraftment, and decreased survival. Existing literature on HLA desensitization has primarily focused on haploidentical transplants, and there is a lack of experience regarding the optimal strategy in UCB transplantation.Methods: We report our successful desensitization strategy in a 42-year-old woman with acute lymphoblastic leukemia receiving a single UCB unit. The only suitable donor option for this patient, who had no relatives and uncommon HLA haplotypes, was a UCB graft against which the patient had DQ7 DSAs.Results: DSA levels were reduced before transplantation through a combination of plasma exchange, intravenous immunoglobulins, and rituximab with close monitoring of DSA mean fluorescent intensity levels. After desensitization, the patient underwent UCB transplantation, achieved successful engraftment and remained in complete remission, free from graft-versus-host disease.Conclusion: When other suitable donors without DSAs are unavailable, our desensitization modality offers a safe option for single-unit UCB transplantation.https://www.tandfonline.com/doi/10.1080/16078454.2024.2448552Umbilical cord bloodhematopoietic cell transplantdonor-specific antibodiesdesensitizationanti-HLAalloimmunization |
| spellingShingle | Mégane Tanguay Sandra Cohen Isabelle Ménard Marie-Christine Meunier Jean-Sébastien Delisle Jean Roy Olivier Veilleux Imran Ahmad Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient Hematology Umbilical cord blood hematopoietic cell transplant donor-specific antibodies desensitization anti-HLA alloimmunization |
| title | Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient |
| title_full | Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient |
| title_fullStr | Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient |
| title_full_unstemmed | Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient |
| title_short | Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient |
| title_sort | successful desensitization of donor specific antibodies in a single cord blood transplant recipient |
| topic | Umbilical cord blood hematopoietic cell transplant donor-specific antibodies desensitization anti-HLA alloimmunization |
| url | https://www.tandfonline.com/doi/10.1080/16078454.2024.2448552 |
| work_keys_str_mv | AT meganetanguay successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT sandracohen successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT isabellemenard successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT mariechristinemeunier successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT jeansebastiendelisle successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT jeanroy successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT olivierveilleux successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient AT imranahmad successfuldesensitizationofdonorspecificantibodiesinasinglecordbloodtransplantrecipient |